Hubei Minkang Pharmaceutical LTD (HBMK) financial statements (2021 and earlier)

Company profile

Business Address 55 UBI AVE, #03-01
MINTWELL BUILDING, 408864
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4,8005,6215,3086,2345,6155,4174,927
Cash and cash equivalents4,8005,6215,3086,2345,6155,4174,927
Receivables1,0971,2321,1429561,5801,4511,375
Inventory, net of allowances, customer advances and progress billings3,8153,6663,7383,9853,8594,2434,195
Inventory3,8153,6663,7383,9853,8594,2434,195
Advances on inventory purchases628554581576632515602
Deposits current assets585585584589586  
Prepaid expense and other current assets412
Other current assets2647101,5131,575370730 
Other undisclosed current assets7618558376858319511,753
Total current assets:11,95013,22413,70414,59913,47313,30713,264
Noncurrent Assets
Property, plant and equipment4,4164,5114,6034,7404,9154,9294,826
Other undisclosed noncurrent assets2,0762,1372,1962,2762,3262,3732,398
Total noncurrent assets:6,4926,6476,7987,0167,2407,3027,224
TOTAL ASSETS:18,44219,87120,50221,61520,71320,60920,488
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,7121,6521,9772,2782,7112,6212,973
Accounts payable1,7121,6521,9772,2782,7112,6212,973
Debt3,2503,2493,2453,2723,2553,2363,188
Other liabilities349363376393404416423
Other undisclosed current liabilities2,5153,9903,6554,2452,7433,2203,183
Total current liabilities:7,8269,2539,25310,1889,1149,4939,766
Noncurrent Liabilities
Total liabilities:7,8269,2539,25310,1889,1149,4939,766
Stockholders' equity
Stockholders' equity attributable to parent10,61610,61811,25011,42711,60011,11610,722
Common stock52525252525252
Additional paid in capital5,8245,8245,8245,8245,8245,8245,824
Accumulated other comprehensive income1,6391,6371,6231,7181,6621,5901,426
Retained earnings3,1003,1063,7513,8334,0613,6493,419
Total stockholders' equity:10,61610,61811,25011,42711,60011,11610,722
TOTAL LIABILITIES AND EQUITY:18,44219,87120,50221,61520,71320,60920,488

Income statement (P&L) ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Revenues2,0131,6812,8853,7514,3153,9452,732
Cost of revenue
(Cost of Goods and Services Sold)
(979)(1,146)(1,725)(2,411)(2,210)(2,443)(1,618)
Other undisclosed gross profit  49230(2)  
Gross profit:1,0335351,2091,5712,1031,5021,114
Operating expenses(1,033)(1,109)(1,354)(1,944)(1,537)(1,474)(1,409)
Other undisclosed operating income (loss)(20)(16)48162(27)(63)45
Operating income (loss):(20)(590)(97)(211)539(36)(250)
Nonoperating income (expense)15(42)19(41)(37)146(36)
Investment income, nonoperating8888877
Other nonoperating income (expense)62514(8)(4)(0)0
Interest and debt expense(55)(55)(55)(55)(55)(54)(57)
Other undisclosed income from continuing operations before equity method investments, income taxes55555555555457
Income (loss) from continuing operations before income taxes:(5)(632)(78)(252)502110(286)
Income tax expense (benefit)0(13)(4)24(90)119 
Net income (loss) available to common stockholders, diluted:(5)(645)(82)(228)412230(286)

Comprehensive Income ($ in thousands)

9/30/2014
Q3
6/30/2014
Q2
3/31/2014
Q1
12/31/2013
Q4
9/30/2013
Q3
6/30/2013
Q2
3/31/2013
Q1
Net income (loss):(5)(645)(82)(228)412230(286)
Comprehensive income (loss):(5)(645)(82)(228)412230(286)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent314(96)567216455
Comprehensive income (loss), net of tax, attributable to parent:(3)(631)(178)(172)484394(231)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: